Lightspeed est nommée l’un des meilleurs employeurs de Montréal pour 2024
MONTRÉAL, 29 févr. 2024 (GLOBE NEWSWIRE) — Lightspeed Commerce Inc. (NYSE | TSX : LSPD) est fière d’annoncer qu’elle a […]
Lightspeed Named One of Montréal’s Top Employers for 2024
MONTREAL, Feb. 29, 2024 (GLOBE NEWSWIRE) — Lightspeed Commerce Inc. (NYSE | TSX: LSPD) is proud to announce, for the […]
Studio City International Holdings Limited Announces Unaudited Fourth Quarter 2023 Earnings
MACAU, Feb. 29, 2024 (GLOBE NEWSWIRE) — Studio City International Holdings Limited (NYSE: MSC) (“Studio City” or the “Company”), a […]
Freedom of Mobility Forum Gathers Experts with Divergent Views to Debate Future of Mobility
Freedom of Mobility Forum Gathers Experts with Divergent Views to Debate Future of Mobility Scheduled for April 3, 2024, the […]
Melco Announces Unaudited Fourth Quarter 2023 Earnings
MACAU, Feb. 29, 2024 (GLOBE NEWSWIRE) — Melco Resorts & Entertainment Limited (Nasdaq: MLCO) (“Melco” or the “Company”), a developer, […]
Ocean Biomedical (NASDAQ: OCEA) Announces Joint Venture Partner, Virion Therapeutics to Present Their First Clinical Study Data as an Accepted Late Breaker Presentation at 2024 APASL Global Liver Meeting
Providence, RI, Feb. 29, 2024 (GLOBE NEWSWIRE) — Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharma company which endeavors to accelerate the […]
Achieve Life Sciences Reaches Agreement with the FDA on Long-Term Cytisinicline Exposure Data Requirements for NDA Submission
SEATTLE and VANCOUVER, British Columbia, Feb. 29, 2024 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical […]
Phathom Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 7, 2024
Management to host conference call on Thursday, March 7, 2024, at 8:30 a.m. ET FLORHAM PARK, N.J., Feb. 29, 2024 […]
Nanox and Beilinson Hospital Announce Collaboration to Study Diagnostic Capabilities of Nanox.ARC for Detection of Lung and Chest Diseases
First patients in clinical study at Beilinson Hospital were scanned with the Nanox.ARC, a stationary X-ray system that produces 3D […]
Clene Presents Clinical Results of CNM-Au8® 30mg Treatment From Visionary-MS Trial Long-Term Extension at Annual ACTRIMS Forum 2024
Long-term CNM-Au8 treatment demonstrated significant and clinically meaningful improvement of vision as measured by low contrast letter acuity (LCLA), an […]
